Cerebrix Injection

Composition: Cerebroprotein Hydrolysate 60 mg

Cerebrix Injection is a neuro-supportive injectable formulation from DrugsWell, containing Cerebroprotein Hydrolysate 60 mg. It is positioned for doctor-guided neurological recovery care, especially in conditions where brain cells, nerve signalling, and functional recovery require focused clinical support.

Brain-related conditions such as stroke, head injury, or other neurological damage can affect movement, speech, memory, attention, behaviour, and daily independence. Recovery in such patients is often gradual and usually involves medicines, monitoring, physiotherapy, rehabilitation, family support, and regular follow-up with the treating doctor.

Cerebrix Injection is not a routine painkiller or general weakness injection. It is a prescription neurological support injection that should be used only when advised by a qualified medical professional. The dose, route, duration, and treatment schedule should be decided by the doctor based on the patient’s diagnosis, age, severity, hospital condition, other medicines, and recovery goals.

For doctors, Cerebrix Injection offers a Cerebroprotein Hydrolysate 60 mg option for structured neurological care where neurotrophic support is clinically considered. It fits into treatment planning where recovery support, brain function support, and rehabilitation-focused care are important parts of patient management.

For patients and caregivers, Cerebrix Injection should be understood as a doctor-administered treatment used as part of a broader neurological recovery plan. It does not replace emergency stroke care, surgery, rehabilitation, physiotherapy, or regular medical follow-up. Its use should always remain under medical supervision.

Patients or caregivers should inform the doctor about ongoing medicines, allergies, seizure history, kidney or liver concerns, pregnancy, breastfeeding, or any unusual reaction during treatment.